DNLI 30.76 (+0.26%)
US24823R1059BiotechnologyBiotechnology

Denali Therapeutics (DNLI) Financial Metrics

This table shows a selected set of financial data points of Denali Therapeutics (DNLI). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.06 0 -20.3 2.95B -0.11 330.53M -370.93M -179.97M -145.22M 127.11M
2022 -2.6 0 -10.71 3.49B -0.23 108.46M -262.55M -330.36M -325.99M 218.04M
2021 -2.39 0 -18.65 5.42B -0.19 48.66M -219.89M -287.16M -290.58M 293.48M
2020 0.65 0 128.31 9.13B 0.07 335.66M 413.06M 71.25M 71.14M 507.14M
2019 -2.07 0 -8.43 1.67B -0.33 26.68M -169.5M -213.18M -197.61M 79.45M
2018 -0.39 0 -52.8 1.91B -0.06 129.16M 46.72M -28.83M -36.24M 77.12M
2017 -5.89 0 -2.65 234.04M -0.23 0 -79.51M -85.1M -88.19M 218.38M
2016 -1.77 0 0 0 -0.56 0 -78.49M -85.18M -86.65M 39.85M
2015 -5.58 0 0 0 0 0 -18.11M -16.67M -16.79M 30.74M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.